Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 621, Issue 1-2, 2007, Pages 95-105

  Nair, Jagadeesan ^a   De Flora, Silvio ^b   Izzotti, Alberto ^b   Bartsch, Helmut ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Atherogenic risk factors; Cigarette smoke carcinogenesis; DNA adduct formation; Human atherosclerotic plaques; Inflammation

Indexed keywords

1,N6 ETHENODEOXYADENINE; 3,N4 ETHENODEOXYCYTOSINE; ALDEHYDE DERIVATIVE; DEOXYADENOSINE DERIVATIVE; DEOXYCYTIDINE; DNA; HYDROXY 2 NONENAL; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; DNA DAMAGE; DNA DETERMINATION; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; PRIORITY JOURNAL; SMOKING;

AGED; AGED, 80 AND OVER; ANIMALS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; DEOXYADENOSINES; DEOXYCYTIDINE; DNA ADDUCTS; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; SMOKING;

EID: 34447289608     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.02.013     Document Type: Article

References (75)

1. De Flora S., Izzotti A., Randerath K., Randerath E., Bartsch H., Nair J., Balansky R., van Schooten F., Degan P., Fronza G., Walsh D., and Lewtas J. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine. Mutat. Res. 366 (1996) 197-238
2. Andreassi M.G., Botto N., Colombo M.G., Biagini A., and Clerico A. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?. Environ. Mol. Mutagen. 35 (2002) 265-269
3. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., and Ginsburg G.S. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann. N. Y. Acad. Sci. 947 (2001) 271-292
4. Andreassi M.G. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat. Res. 543 (2003) 67-86
5. Vassalle C., Petrozzi L., Botto N., Andreassi M.G., and Zucchelli G.C. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J. Intern. Med. 256 (2004) 308-315
6. Shields P.G. Epidemiology of tobacco carcinogenesis. Curr. Oncol. Rep. 2 (2000) 257-262
7. Wood D. Established and emerging cardiovascular risk factors. Am. Heart J. 141 (2001) 49-57
8. Benditt E.P., and Benditt J.M. Evidence for an monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 1753-1756
9. Ross R.E., Glomset J.A., and Atherosclerosis. the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180 (1973) 1332-1339
10. Bridges B.S., Bowyer D.E., Hansen E.S., Penn A., and Wakabayashi K. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Mutat. Res. 239 (1990) 143-148
11. Penn A. Mutational events in the etiology of atherosclerotic plaques. Mutat. Res. 239 (1990) 149-162
12. Izzotti A., De Flora S., Petrilli G.L., Gallagher J., Rojas M., Alexandrov K., Bartsch H., and Lewtas J. Cancer biomarkers in human atherosclerotic lesions. I. Detection of DNA adducts. Cancer Epidem. Biomarkers Prev. 4 (1995) 105-110
13. De Flora S., Izzotti A., Walsh A., Degan P., Petrilli G.L., and Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 11 (1997) 1021-1031
14. Markowitz S.D. Atherosclerosis, just another cancer?. J. Clin. Invest. 100 (1997) 2143-2145
15. Andreassi M.G., Botto N., Colombo M.G., Biagini A., and Clerico A. Genetic instability and atherosclerosis: can somatic mutation account for the development of cardiovascular diseases?. Environ. Mol. Mutagen. 35 (2000) 265-269
16. Izzotti A., Cartiglia C., Lewtas J., De Flora S., and Increased. DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J. 15 (2001) 752-757
17. Li R., Folsom A.R., Sharrett A.R., Couper D., Bray M., and Tyroler H.A. Interaction of the glutathione S-transferase genes and cigarette smoking on risk of lower extremity arterial disease: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154 (2001) 729-738
18. Binkova B., Smerhovsky Z., Strejc P., Boubelik O., Stavkova Z., Chvatalova I., and Sram R.J. DNA-adducts and atheroclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat. Res. 501 (2002) 15-28
19. Spandidos D.A., Ergazaki M., Arvanitis D., and Kiaris H. Microsatellite instability in human atherosclerotic plaques. Biochem. Biophys. Res. Commun. 220 (1996) 137-140
20. Hatzistamou J., Kiaris H., Ergazaki M., and Spandidos D.A. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem. Biophys. Res. Commun. 225 (1996) 186-190
21. McCaffrey T.A., Du B., Consigli S., Szabo P., Bray P.J., Hartner L., Weksler B.B., Sanborn T.A., Bergman G., and Bush Jr. H.L. Genomic instability in the type II TGF-beta 1 receptor gene in atherosclerotic and restenotic vascular cells. J. Clin. Invest. 100 (1997) 2182-2188
22. Clark K.J., Cary N.R., Grace A.A., and Metcalfe J.C. Microsatellite mutation of type lI transforming growth factor-beta receptor is rare in atherosclerotic plaques. Atherosler. Thromb. Vasc. Biol. 21 (2001) 555-559
23. Grati F.R., Ghilardi G., Sirchia S.M., Massaro F., Cassani B., Scorza R., De Andreis C., Sironi E., and Simoni G. Loss of heterozygosity of the NOS3 dinucleotide repeat marker in atherosclerotic plaques of human carotid arteries. Atherosclerosis 159 (2001) 261-267
24. Miniati P., Sourvinos G., Michalodimitrakis M., and Spandidos D.A. Loss of heterozygosity on chromosomes 1, 2, 8, 9 and 17 in cerebral atherosclerotic plaques. Int. J. Biol. Markers 16 (2001) 167-171
25. Vanni R., and Licheri S. Clonal cytogenetic change in atherosclerotic plaques including trisomy 20. Dis. Markers 9 (1991) 81-85
26. Casalone R., Granata P., Minelli E., Portentoso P., Guidici A., Righi R., Castelli P., Socrate A., and Frigerio B. Cytogenetic analysis reveals clonal proliferation of smooth-muscle cells in atherosclerotic plaques. Hum. Genet. 87 (1991) 143-149
27. Matturri L., Cazzullo A., Turconi P., Lavezzi A.M., Vandone P.L., Gabrielli G., Fernandez Alonso G., Grana D., and Milei J. Chromosomal alterations in atherosclerotic plaques. Atherosclerosis 154 (2001) 755-761
28. Van Schooten F.J., Hirvonen L.M., Maas B.A., De Mol B.A., Kleinjans J.C., Bell D.A., and Durrer J.D. Putative susceptibility markers of coronary artery disease-association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J. 12 (1998) 1409-1417
29. Zhang Y.J., Weksler B.B., Wang L.Y., Schwartz J., and Santella R.M. Immunohistochemical detection of polycyclic aromatic hydrocarbon DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 140 (1998) 325-331
30. Craig W.Y., Palomaki G.E., and Haddow J.E. Cigarette smoking und serum lipid and lipoprotein concentrations: an analysis of published data. Br. Med. J. 298 (1989) 784-788
31. Heitzer T., Yla-Herttuala S., Luoma J., Kurz S., Munzel T., Just H., Olschewski M., and Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93 (1996) 1346-1353
32. Tracy R.P., Psatv B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., and Kuller L.H. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Atheroscler. Thromb. Vasc. Biol. 17 (1997) 2167-2176
33. Bermudez E.A., Rifai N., Buring J.E., Manson J.E., and Ridker P.M. Relation between markers of systemic vascular inflammation and smoking in women. Am. J. Cardiol. 89 (2002) 1117-1119
34. Ambrose J.A., and Barua R.S. Tlre pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43 (2004) 1731-1737
35. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
36. Marcy T.W., and Merrill W.W. Cigarette smoking and respiratory tract infection. Clin. Chest Med. 8 (1987) 381-391
37. Bernhard D., Csordas A., Henderson D., Rossmann A., Kind M., and Wick G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J. 19 (2005) 1096-1107
38. Bartsch H., and Nair J. Oxidative stress and lipid peroxidation-derived DNA-lesions in inflammation driven carcinogenesis. Review. Cancer Detect. Prev. 28 (2004) 385-391
39. Chung F.L., Chen H.J.C., and Nath R.G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 17 (1996) 2105-2111
40. Chung F.L., Nath R.G., Ocando J., Nishikawa A., and Zhang L. Deoxyguanosine adducts of t-4-llydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res. 60 (2000) 1507-1511
41. Singer B., and Bartsch H. Exocyclic DNA adducts in mutagenesis and carcinogenesis 150 (1999), IARC Scientific Publications, Lyon pp. 1-36
42. Nair J., Gansauge F., Beger H., Dolara P., Winde G., and Bartsch H. Increased etheno DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis and chronic pancreatitis. Antioxid. Redox Signal 8 (2006) 1003-1010
43. 32P-postlabeling. Carcinogenesis 16 (1995) 513-517
44. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28 (2000) 1815-1826
45. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 36 (2001) 41-44
46. D. Steinberg, J.L. Witztum, Lipoprotein, lipoprotein oxidation, and atherogenesis, in: Molecular Basis of Cardiovascular Disease, vol. 1499, Saunders, Philadelphia, 1999, pp. 458-475.
47. S. Tsimikas, J.L. Witztum, The oxidative modification hypothesis of atherogenesis, in: Oxidative Stress and Vascular Disease, Kluwer Academic Publishers, Norwell, pp. 49-79.
48. Palinski W., Ord V.A., Plump A.S., Breslow J.L., Steinberg D., and Witztum J.L. ApoE-deficient mice are a model of lipoprotein oxidation in atherosclerosis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Atheroscler. Thromb. 14 (1994) 605-616
49. 4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chem. Res. Toxicol. 8 (1995) 278-283
50. Barbin A. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutat. Res. 462 (2000) 55-69
51. Godschalk R., Curfs D., Bartsch H., van Schooten F.J., and Nair J. Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice. Free Radic. Res. 37 (2003) 1299-1305
52. Gedik C.M., and Collins A. Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J. 19 (2005) 82-84
53. Nair J., Vaca C.E., Velic I., Mutanen M., Valsta L.M., and Bartsch H. High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 597-601
54. Nair J. Lipid peroxidation-induced etheno-DNA adducts in humans. Exocyclic DNA Adducts in Mutagenesis and Carcinogenesis 150 (1999), IARC Scientific Publications, Lyon pp. 55-61
55. Barbin A., Ohgaki H., Nakamura J., Kurrer M., Kleihues P., and Swenberg J.A. Endogenous deoxyribonucleic acid (DNA) damage in human tissues: a comparison of ethenobases with aldehydic DNA lesions. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 1241-1247
56. 4-ethenocytosine are excised by separate human DNA glycosylases. Carcinogenesis 17 (1996) 155-157
57. 6-ethenoadenine when present in DNA. Nucleic Acids Res. 23 (1995) 3750-3755
58. Gros L., Ishchenko A.A., and Saparbaev M. Enzymology of repair of etheno-adducts. Mutat. Res. 531 (2003) 219-229
59. Delaney J.C., Smeester L., Wong C., Frick L.E., Taghizadeh K., Wishnok J.S., Drennan C.L., Samson L.D., and Essigmann J.M. AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. Nat. Struct. Mol. Biol. 12 (2005) 855-860
60. 6-ethenoadenine by the DNA repair AIkB proteins. J. Am. Chem. Soc. 127 (2005) 14594-14595
61. 4-ethenocytosine, a lipid peroxidation-induced DNA adduct. J. Biol. Chem. 279 (2004) 17723-17730
62. Feng Z., Hu W., and Tang M.S. Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 8598-8602
63. Feng Z., Hu W., Amin S., and Tang M.S. Mutational spectrum and genotoxicity of the major lipid peroxidation product, trans-4-hydroxy-2-nonenal, induced DNA adducts in nucleotide excision repair-proficient and -deficient human cells. Biochemistry 42 (2003) 7848-7854
64. Hofseth L.J., Khan M.A., Ambrose M., Nikolayeva O., Xu-Welliver M., Kartalou M., Hussain S.P., Roth R.B., Zhou X., Mechanic L.E., Zurer I., Rotter V., Samson L.D., and Harris C.C. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J. Clin. Invest. 112 (2003) 1887-1894
65. Kannel W.B. Update on the role of cigarette smoking in coronary artery diseases. Am. Heart. J. 101 (1981) 319-328
66. Hansen E.S. Shared risk factors for cancer and athero-sclerosis-a review of the epidemiological evidence. Mutat. Res. 289 (1990) 163-179
67. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567 (2004) 447-474
68. 4-etheno-2′-deoxycytidine in humans as a biomarker of oxidative stress: association with cigarette smoking. Chem. Res. Toxicol. 17 (2004) 896-903
69. Curfs D.M., Lutgens E., Gijbels M.J., Kockx M.M., Daemen M.J., and van Schooten F.J. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am. J. Pathol. 164 (2004) 101-108
70. Penn A., and Snyder C. Atherosclerotic plaque development is "promoted" by polynuclear aromatic hydrocarbons. Carcinogenesis 9 (1988) 2185-2189
71. Kim H.S., Kwack S.J., and Lee B.M. Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrenequinones in the blood of rats treated with benzo[a]pyrene. Chem. Biol. Interact. 127 (2000) 139-150
72. Curfs D.M., Knaapen A.M., Pachen D.M., Gijbels M.J., Lutgens E., Smook M.L., Kockx M.M., Daemen M.J., and van Schooten F.J. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB. J. 19 (2005) 1290-1292
73. Ohshima H., Tatemichi M., and Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417 (2003) 3-11
74. Izzotti A., Camoirano A., Cartiglia C., Tampa E., and De Flora S. Formation of DNA adducts in the aorta of smoke-exposed rats. Modulation by five chemopreventive agents. Mutat. Res. 494 (2001) 97-106
75. 2-etheno-2'-deoxyguanosine adducts. Chem. Res. Toxicol. 18 (2005) 780-786